La Jolla Pharmaceutical OverviewTrack La Jolla Pharmaceutical's operating income ($14M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
La Jolla Pharmaceutical (LJPC) currently reports a operating income of $14M as of June 2022. That compares with $8.4M in the prior-year period — up 67.2% year over year. Use the charts on this page to explore La Jolla Pharmaceutical's operating income history and peer comparisons.
La Jolla Pharmaceutical's operating income increased from $8.4M to $14M — a 67.2% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
La Jolla Pharmaceutical reported $14M in operating income as of June 2022. That compares with $8.4M in the prior-year period — up 67.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for La Jolla Pharmaceutical, and consider following LJPC for alerts when major investors trade the stock.
La Jolla Pharmaceutical is classified in the Healthcare sector. On operating income, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LJPC with unrelated industries.
